Amlodipine Besylate
Product Images NDC 53808-1029

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Amlodipine Besylate (NDC 53808-1029). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by State Of Florida Doh Central Pharmacy, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Label Image For 5mg (Qualitest)

Label Image For 5mg (Qualitest)
This is a description of a medication called Amlodipine Besylate which comes in 5mg tablets. The quantity is 30 and it is only available with a prescription. It has a lot number of LOTT010D138 and a package number of 0210201463. Its expiration date is 08-10-2014 and it was packaged by DOH Central Pharmacy in Tallahassee, FL 32304. It also has a UPC number of 306032100288.*
FDA Label Image

This Is An Image Of The Structural Formula For Amlodipine Besylate. (Amlodusp 1)

This Is An Image Of The Structural Formula For Amlodipine Besylate. (Amlodusp 1)
FDA Label Image

Figure 1 (Kaplan-Meier Analysis of Composite Clinical Outcomes for Amlodipine versus Placebo)

Figure 1 (Kaplan-Meier Analysis of Composite Clinical Outcomes for Amlodipine versus Placebo)
This appears to be a table or graph displaying the event rate, p-value, hazard ratio, and confidence interval for a drug called Amlodipine. It also shows a time frame in months. It is not clear what kind of event is being measured or what the numbers represent without additional context.*
FDA Label Image

Figure 2 (Effects on Primary Endpoint of Amlodipine versus Placebo across Sub-Groups)

Figure 2 (Effects on Primary Endpoint of Amlodipine versus Placebo across Sub-Groups)
This text appears to show the results of a study comparing the effects of Amlodipine against a placebo in patients with various characteristics such as age, gender, and baseline blood pressure. Other characteristics such as the presence of vessel disease or stenosis are also mentioned. The text contains various tables and statistics related to the study results, including hazard ratios with confidence intervals. Overall, it seems to be a clinical report or research paper, but without further context, it is difficult to say more.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.